Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Symanska, Kazia
DOB: 04-MAR-1952 (Age: 73)
Gender: female
Address:
ul. Celna 102
70-644 Szczecin (Poland)
ID: 4349-062082-0
Report
Date: 10-MAY-2024
Laboratory
Requested by
4: Radioterapia, Komisja onkologiczna
70-560 Szczecin (Poland)
Specimen
Collected: 09-MAY-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 09 May 2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.6 4.3 - 6.4 %
Glucose [Mass/volume] in Blood 85.4 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 13.8 7 - 43 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.8 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 136.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5 mmol/L
Chloride [Moles/volume] in Blood 108.0 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.1 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 171.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 121.5 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 90.2 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.3 50 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 15.2 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All results are within or close to normal limits, with only a mildly elevated potassium (5.2 mmol/L) in 2024 and a slightly high chloride (110.7 mmol/L) in 2023, both likely of minimal clinical significance. Renal function, glucose control, and lipid profile are stable and unremarkable. No evidence of significant metabolic or renal dysfunction. Recommend routine monitoring.